Matt Doogue is a consultant physician at Christchurch Hospital in Clinical Pharmacology and General Medicine. He is a member of the Department of Medicine, University of Otago, Christchurch and co-convenes clinical pharmacology teaching. He has roles in medicines governance.
His interests are broadly in quality use of medicines and include: medicines systems, adverse drug reactions, pharmacogenetics, applied pharmacokinetics, clinical decision support, and pharmacoinformatics.
Publications
Sundermann, M., Clendon, O., McNeill, R., Doogue, M., & Chin, P. K. L. (2024). Optimising interruptive clinical decision support alerts for antithrombotic duplicate prescribing in hospital. International Journal of Medical Informatics, 186, 104418. doi: 10.1016/j.ijmedinf.2024.105418 Journal - Research Article
Drake, R., Prael, G., Phyo, Y., Chang, S., Hunt, J., Herbert, A., … Doogue, M., … Currow, D. (2023). Gabapentin for pain in pediatric palliative care. Journal of Pain & Symptom Management. Advance online publication. doi: 10.1016/j.jpainsymman.2023.11.011 Journal - Research Article
Pairman, L., Chin, P., McNeill, R., & Doogue, M. (2023). The effect of compulsory indications in electronic hospital prescriptions on prescriber behaviour. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Annual Scientific Meeting: Transformational Pharmacology and Toxicology. 435. Retrieved from https://www.asceptasm.com Conference Contribution - Published proceedings: Abstract
Doogue, M. P. (2023). Clinical decision support in prescribing systems to mitigate risks from pharmacokinetic drug-drug interactions. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Annual Scientific Meeting: Transformational Pharmacology and Toxicology. 313. Retrieved from https://www.asceptasm.com Conference Contribution - Published proceedings: Abstract
Zhang, M., Moore, G., Chin, P. K. L., & Doogue, M. (2023). An efficient HILIC-MS/MS method for monitoring metformin in human plasma. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Annual Scientific Meeting: Transformational Pharmacology and Toxicology. P510. Retrieved from https://www.asceptasm.com Conference Contribution - Published proceedings: Abstract
2024
Journal - Research Article
Sundermann, M., Clendon, O., McNeill, R., Doogue, M., & Chin, P. K. L. (2024). Optimising interruptive clinical decision support alerts for antithrombotic duplicate prescribing in hospital. International Journal of Medical Informatics, 186, 104418. doi: 10.1016/j.ijmedinf.2024.105418
2023
Journal - Research Article
Drake, R., Prael, G., Phyo, Y., Chang, S., Hunt, J., Herbert, A., … Doogue, M., … Currow, D. (2023). Gabapentin for pain in pediatric palliative care. Journal of Pain & Symptom Management. Advance online publication. doi: 10.1016/j.jpainsymman.2023.11.011
Chin, P. K. L., Charles, K., Murnion, B., McGuire, T. M., Hilmer, S. N., Martin, J., Reith, D., … Doogue, M., … O'Mara, D. (2023). Evaluation of the Prescribing Skills Assessment implementation, performance and medical student experience in Australia and New Zealand. British Journal of Clinical Pharmacology, 89, 3105-3115. doi: 10.1111/bcp.15814
Wang, M., Barclay, M. L., Chin, P. K. L., & Doogue, M. P. (2023). Changes in inpatient medicine prescribing during Covid-19 lockdown. Internal Medicine Journal, 53, 917-922. doi: 10.1111/imj.15996
Conference Contribution - Published proceedings: Abstract
Pairman, L., Chin, P., McNeill, R., & Doogue, M. (2023). The effect of compulsory indications in electronic hospital prescriptions on prescriber behaviour. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Annual Scientific Meeting: Transformational Pharmacology and Toxicology. 435. Retrieved from https://www.asceptasm.com
Doogue, M. P. (2023). Clinical decision support in prescribing systems to mitigate risks from pharmacokinetic drug-drug interactions. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Annual Scientific Meeting: Transformational Pharmacology and Toxicology. 313. Retrieved from https://www.asceptasm.com
Zhang, M., Moore, G., Chin, P. K. L., & Doogue, M. (2023). An efficient HILIC-MS/MS method for monitoring metformin in human plasma. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Annual Scientific Meeting: Transformational Pharmacology and Toxicology. P510. Retrieved from https://www.asceptasm.com
Conference Contribution - Verbal presentation and other Conference outputs
Doogue, M., & Pairman, L. (2023, August-September). A systems overview of the clinical data environment for evaluating medicines use in NZ hospitals. Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists New Zealand Section (ASCEPT-NZ) Annual Scientific Meeting, Queenstown, New Zealand.
2022
Journal - Research Article
Seah, D. S. E., Wilcock, A., Chang, S., Sousa, M. S., Sinnarajah, A., Teoh, C. O., … Doogue, M., … Currow, D. C. (2022). Paracentesis for cancer-related ascites in palliative care: An international, prospective cohort study. Palliative Medicine, 36(9), 1408-1417. doi: 10.1177/02692163221122326
Hussein, A., Digges, M., Chang, S., Hunt, J., Doogue, M., Rowett, D., … Currow, D. C. (2022). Pharmacovigilance in hospice/palliative care: Net effect of amitriptyline or nortriptyline on neuropathic pain: UTS/IMPACCT Rapid programme international consecutive cohort. Palliative Medicine, 36(6), 938-944. doi: 10.1177/02692163221085855
Palmer, D., Soule, S., Gaddam, R. R., Elder, P., Chambers, S., & Doogue, M. (2022). Unbound vitamin D concentrations are not decreased in critically ill patients. Internal Medicine Journal, 52, 89-94. doi: 10.1111/imj.15096
Livirya, S., Pithie, A., Chua, I., Hamilton, N., Doogue, M., & Isenman, H. (2022). Oral amoxicillin challenge for low risk penicillin allergic patients. Internal Medicine Journal, 52, 295-300. doi: 10.1111/imj.14978
Journal - Research Other
Mortensen, J. S., Jensen, B. P., & Doogue, M. (2022). Pre-analytical stability of flucloxacillin, piperacillin, tazobactam, meropenem, cefalexin, cefazolin, and ceftazidime in therapeutic drug monitoring: A structured review. Therapeutic Drug Monitoring, 44(6), 709-719. doi: 10.1097/ftd.0000000000000975
Walter, T., Connor, S., Stedman, C., & Doogue, M. (2022). A case of acute necrotising pancreatitis following the second dose of Pfizer-BioNTech COVID-19 mRNA vaccine. British Journal of Clinical Pharmacology, 88, 1385-1386. doi: 10.1111/bcp.15039
Conference Contribution - Published proceedings: Abstract
Kerse, K. E. G., & Doogue, M. (2022). Prescribing patterns in very elderly inpatients in Christchurch, New Zealand. Proceedings of the Australasian Pharmaceutical Science Association (APSA) and the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Joint Conference. 516. Retrieved from https://www.asceptasm.com
Pairman, L., McNeill, R., Chin, P., & Doogue, M. (2022). Using electronic prescription and laboratory data to assess prescribing practice. Proceedings of the Australasian Pharmaceutical Science Association (APSA) and the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Joint Conference. 111. Retrieved from https://www.asceptasm.com
Conference Contribution - Verbal presentation and other Conference outputs
Pairman, L., Chin, P., Gardiner, S., & Doogue, M. (2022, August-September). The effect of mandatory prescription indications for antibacterials. Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) NZ Annual Scientific Meeting, Queenstown, New Zealand.
Liau, Y., Maggo, S., Lehnert, K., Doogue, M. P., Scull, A., Miller, A. L., Pearson, J. F., & Kennedy, M. A. (2022, August-September). Genomic analysis of angiotensin converting enzyme inhibitor-induced angioedema. Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) NZ Annual Scientific Meeting, Queenstown, New Zealand.
2021
Journal - Research Article
McNeill, R. P., Zhang, M., Epton, M. J., & Doogue, M. P. (2021). Drub metabolism in severe chronic obstructive pulmonary disease: A phenotyping cocktail study. British Journal of Clinical Pharmacology, 87, 4397-4407. doi: 10.1111/bcp.14862
Crake, R. L. I., Strother, M. R., Phillips, E., Doogue, M. P., Zhang, M., Frampton, C. M. A., Robinson, B. A., & Currie, M. J. (2021). Influence of serum inflammatory cytokines on cytochrome P450 drug metabolising activity during breast cancer chemotherapy: A patient feasibility study. Scientific Reports, 11(1), 5648. doi: 10.1038/s41598-021-85048-1
Journal - Research Other
Wilkinson, T., Soule, S., & Doogue, M. (2021). Syndrome of inappropriate anti-diuretic hormone secondary to transient global amnesia. Internal Medicine Journal, 51(7), 1186-1187. doi: 10.1111/imj.15410
Conference Contribution - Published proceedings: Abstract
Maggo, S., Kee, J., Hitchman, L., Chin, P., Doogue, M., Miller, A., … Kennedy, M. (2021). Assessing the pharmacogenomic landscape of adverse drug reactions in Aotearoa [Invited]. Proceedings of the Genetics Otago (GO) Annual Symposium. Retrieved from https://blogs.otago.ac.nz/go
2020
Journal - Research Article
O'Grady, M., Clarke, L., Turner, G., Doogue, M., Purcell, R., Pearson, J., & Frizelle, F. (2020). Statin use and risk of acute diverticulitis: A population-based case-control study. Medicine, 99(20), e20264. doi: 10.1097/md.0000000000020264
Gardiner, S. J., Metcalf, S. C. L., Werno, A., Doogue, M. P., Chambers, S. T., on behalf of the Canterbury District Health Board Antimicrobial Stewardship Committee. (2020). A persuasive approach to antimicrobial stewardship in Christchurch hospitals produced a sustained decrease in intravenous clarithromycin dosing and expenditure via a switch to azithromycin orally. New Zealand Medical Journal, 133(1512), 22-30. Retrieved from https://www.nzma.org.nz/journal
Chin, P. K. L., Chuah, Q., Crawford, A. M., Clendon, O. R., Drennan, P. G., Dalrymple, J. M., Barclay, M. L., & Doogue, M. P. (2020). Clinical decision support in a hospital electronic prescribing system informed by local data: Experience at a tertiary New Zealand centre. Internal Medicine Journal, 50, 1225-1232. doi: 10.1111/imj.14706
Chin, P. K. L., McNeill, R., Lee, H. K., Zhang, M., Jensen, B., Smith, M., & Doogue, M. P. (2020). Routine therapeutic drug monitoring of dabigatran: Experience at a tertiary center. Therapeutic Drug Monitoring, 42(3), 468-472. doi: 10.1097/ftd.0000000000000713
Journal - Research Other
Falconer, N., Spinewine, A., Doogue, M. P., & Barras, M. (2020). Identifying medication harm in hospitalised patients: A bimodal, targeted approach. Therapeutic Advances in Drug Safety, 11, 1-5. doi: 10.1177/2042098620975516
Hunt, J., Brown, L., Fazekas, B., Doogue, M., Rowett, D., Luckett, T., … Currow, D. C. (2020). Evaluation of the IMPACCT Rapid Program: A cross-sectional survey of international site investigators. Journal of Palliative Care, 23(10), 1292-1293. doi: 10.1089/jpm.2020.0239
Sinnappah, K. A., Kuan, I. H. S., Thynne, T. R. J., Doogue, M. P., & Wright, D. F. B. (2020). The pharmacokinetics of metformin in patients receiving intermittent haemodialysis [Short report]. British Journal of Clinical Pharmacology, 86, 1430-1443. doi: 10.1111/bcp.14244
2019
Journal - Research Article
Leggett, C., Giles, L., Anderson, J. J. A., Doogue, M., Couper, J., & Pena, A. S. (2019). Adherence to metformin is reduced during school holidays and weekends in children with type 1 diabetes participating in a randomised controlled trial. Archives of Disease in Childhood, 104, 890-894. doi: 10.1136/archdischild-2018-316303
Currow, D. C., Ekström, M., Louw, S., Hill, J., Fazekas, B., Clark, K., … Doogue, M., … Agar, M. (2019). Sertraline in symptomatic chronic breathlessness: A double blind, randomised trial. European Respiratory Journal, 53, 1801270. doi: 10.1183/13993003.01270-2018
McNeill, R., Chin, P., Coberger, E., & Doogue, M. (2019). A randomised controlled trial of patient information leaflets as a medication counselling aid. Internal Medicine Journal, 49(3), 328-332. doi: 10.1111/imj.14038
Journal - Research Other
Coller, J. K., Ramachandran, J., John, L., Tuke, J., Wigg, A., & Doogue, M. (2019). The impact of liver transplant recipient and donor genetic variability on tacrolimus exposure and transplant outcome [Short report]. British Journal of Clinical Pharmacology, 85, 2170-2175. doi: 10.1111/bcp.14034
Mortensen, J. S., Jensen, B. P., Zhang, M., & Doogue, M. (2019). Pre-analytical stability of piperacillin, tazobactam, meropenem and ceftazidime in plasma and whole blood using LC-MS/MS [Short communication]. Therapeutic Drug Monitoring, 41(4), 538-543. doi: 10.1097/ftd.0000000000000650
Conference Contribution - Published proceedings: Abstract
Liu, W., Liau, Y., Maggo, S., Doogue, M., & Kennedy, M. (2019). Exploring combinatorial genetic contributions to a serious adverse drug reaction. Proceedings of the MapNet Meeting. (pp. 28). Retrieved from http://mapnet2019.nz/
Sinnappah, K. A., Kuan, I. H. S., Thynne, T., Doogue, M., & Wright, D. F. B. (2019). A population pharmacokinetic model for metformin in patients receiving intermittent haemodialysis. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) and the Population Approach Group of Australia and New Zealand (PAGANZ) Joint Scientific Meeting: Shared Horizons: Optimizing Drug Response to Improve Patient Outcomes. (pp. 9). Retrieved from https://www.asceptasm.com
Mortensen, J. S., Jensen, B. P., & Doogue, M. (2019). Determining the pre-analytical instability of beta-Lactam antibiotics in therapeutic drug monitoring samples. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) and the Population Approach Group of Australia and New Zealand (PAGANZ) Joint Scientific Meeting: Shared Horizons: Optimizing Drug Response to Improve Patient Outcomes. (pp. 35). Retrieved from https://www.asceptasm.com
Doogue, M. P., & Chin, P. K. L. (2019). Using patient simulation in the clinical learning environment. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) and the Population Approach Group of Australia and New Zealand (PAGANZ) Joint Scientific Meeting: Shared Horizons: Optimizing Drug Response to Improve Patient Outcomes. (pp. 59). Retrieved from https://www.asceptasm.com
Morahan, M.-C., Coberger, E., Stedman, C., & Doogue, M. (2019). Validity and reliability of clinical resources on adverse effects of medicines: Drug-induced liver injury. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) and the Population Approach Group of Australia and New Zealand (PAGANZ) Joint Scientific Meeting: Shared Horizons: Optimizing Drug Response to Improve Patient Outcomes. (pp. 28). Retrieved from https://www.asceptasm.com
Mortensen, J. S., Jensen, B. P., & Doogue, M. (2019). Simultaneous quantification of four beta-Lactams in human plasma for therapeutic drug monitoring. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) and the Population Approach Group of Australia and New Zealand (PAGANZ) Joint Scientific Meeting: Shared Horizons: Optimizing Drug Response to Improve Patient Outcomes. (pp. 29). Retrieved from https://www.asceptasm.com
Conference Contribution - Verbal presentation and other Conference outputs
Doogue, M. (2019, November). SGLT2 inhibitors in clinical practice. Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) and the Population Approach Group of Australia and New Zealand (PAGANZ) Joint Scientific Meeting: Shared Horizons: Optimizing Drug Response to Improve Patient Outcomes, Queenstown, New Zealand.
2018
Journal - Research Article
Gardiner, S. J., Metcalf, S. C. L., Chin, P. K. L., Doogue, M. P., Dalton, S. C., & Chambers, S. T. (2018). Metronidazole stewardship initiative at Christchurch hospitals: Achievable with immediate benefits. New Zealand Medical Journal, 131(1473), 53-58. Retrieved from https://www.nzma.org.nz/journal
Journal - Research Other
Drennan, P., Doogue, M., van Hal, S. J., & Chin, P. (2018). Bayesian therapeutic drug monitoring software: Past, present and future. International Journal of Pharmacokinetics, 3(4), 109-114. doi: 10.4155/ipk-2018-0005
Okamura-Kho, A., Chuah, Q., Chin, P., & Doogue, M. (2018). Rarely a triple whammy in general medicine. New Zealand Medical Journal, 1476(131), 92-95. Retrieved from https://www.nzma.org.nz/journal
Polasek, T. M., Doogue, M. P., & Thynne, T. R. J. (2018). Metformin treatment of type 2 diabetes mellitus in pregnancy: Update on safety and efficacy. Therapeutic Advances in Drug Safety, 9(6), 287-295. doi: 10.1177/2042098618769831
Conference Contribution - Published proceedings: Abstract
Zhang, M., Moore, G., Doogue, M., & Strother, M. (2018). Simultaneous determination of the phenotyping cocktail drugs and their cytochrome P450-specific probe metabolites in human plasma and urine by liquid chromatography/tandem mass spectrometry. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Annual Scientific Meeting: Innovation in Therapeutics. 422. Retrieved from https://www.asceptasm.com/2018-annaul-scientific-meeting
Maggo, S., Liau, Y., Doogue, M., & Kennedy, M. (2018). Understanding drug reactions using genome sequencing (UDRUGS) study: A New Zealand initiative to investigate the genetics of ADRs. Basic & Clinical Pharmacology & Toxicology, 123(Suppl. 1), (pp. 3). doi: 10.1111/bcpt.13020
Conference Contribution - Verbal presentation and other Conference outputs
Doogue, M., Chin, P., Simpson, C., Frew, G., Hudson, B., & Heppenstall, C. (2018, August). Recording adverse drug reactions in New Zealand. Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists New Zealand Section (ASCEPT-NZ) Annual Scientific Meeting, Queenstown, New Zealand.
Thomas, P. W. A., Chin, P. K. L., Doogue, M. P., & Barclay, M. L. (2018, August). A nationwide survey on therapeutic drug monitoring of anti-tumour necrosis factor agents for inflammatory bowel disease. Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists New Zealand Section (ASCEPT-NZ) Annual Scientific Meeting, Queenstown, New Zealand.
Chin, P. K. L., Lee, M. H., Smith, M., & Doogue, M. P. (2018, August). Real-world dabigatran concentration monitoring: Christchurch experience. Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists New Zealand Section (ASCEPT-NZ) Annual Scientific Meeting, Queenstown, New Zealand.
2017
Journal - Research Article
Maggo, S. D. S., Chua, E. W., Chin, P., Cree, S., Pearson, J., Doogue, M., & Kennedy, M. A. (2017). A New Zealand platform to enable genetic investigation of adverse drug reactions. New Zealand Medical Journal, 130(1466), 62-69. Retrieved from http://www.nzma.org.nz/journal
Wright, D. F. B., Doogue, M. P., Barclay, M. L., Chapman, P. T., Cross, N. B., Irvine, J. H., & Stamp, L. K. (2017). A population pharmacokinetic model to predict oxypurinol exposure in patients on haemodialysis. European Journal of Clinical Pharmacology, 73, 71-78. doi: 10.1007/s00228-016-2133-y
Journal - Professional & Other Non-Research Articles
Kamel, K. S., Chin, P. K. L., Doogue, M. P., & Barclay, M. L. (2017). Comment on: "Effect of age and renal function on idarucizumab pharmacokinetics and idarucizumab-mediated reversal of dabigatran anticoagulant activity in a randomized, double-blind, crossover phase Ib study>". Clinical Pharmacokinetics, 56(2), 207-208. doi: 10.1007/s40262-016-0481-5
Conference Contribution - Published proceedings: Abstract
Zhang, M., Moore, G. A., Doogue, M. P., & Barclay, M. L. (2017). Simultaneous determination of adalimumab and infliximab in human serum by liquid chromatography/tandem mass spectrometry. Proceedings of the Australasian Pharmaceutical Science Association and the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (APSA-ASCEPT) Joint Scientific Meeting. (pp. 60). Retrieved from http://www.asceptasm.com/
Doogue, M., Morahan, M.-C., Coberger, E., & Chin, P. (2017). Severe cutaneous adverse reactions and the (in)accuracy of medicines information sources. Proceedings of the Australasian Pharmaceutical Science Association and the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (APSA-ASCEPT) Joint Scientific Meeting. (pp. 50). Retrieved from http://www.asceptasm.com/
Doogue, M., McNeill, R., Young, M., Wilkinson, J., Pugh, S., Sylevych, V., … Chuah, Q., Hamilton, N., Chua, I., … Barclay, M., & Chin, P. (2017). Making adverse drug reactions visible. Proceedings of the Australasian Pharmaceutical Science Association and the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (APSA-ASCEPT) Joint Scientific Meeting. (pp. 49). Retrieved from http://www.asceptasm.com/
Crawford, A., Chin, P., & Doogue, M. (2017). Antithrombotic drug-drug interaction alerts in MedChart™. Proceedings of the Australasian Pharmaceutical Science Association and the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (APSA-ASCEPT) Joint Scientific Meeting. (pp. 48). Retrieved from http://www.asceptasm.com/
McNeill, R., Chin, P., Coberger, E., & Doogue, M. (2017). A randomised controlled trial of patient information leaflets as a medication counselling tool. Proceedings of the Australasian Pharmaceutical Science Association and the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (APSA-ASCEPT) Joint Scientific Meeting. (pp. 77). Retrieved from http://www.asceptasm.com/
Chin, P. K. L., Chuah, Q., & Doogue, M. P. (2017). Vignettes from hospital-level electronic prescribing data. Proceedings of the Australasian Pharmaceutical Science Association and the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (APSA-ASCEPT) Joint Scientific Meeting. (pp. 58). Retrieved from http://www.asceptasm.com/
Chin, P., Crawford, A., Chuah, Q., & Doogue, M. (2017). Impact of locally customised "blodd thinner" alerts in MedChart™. Proceedings of the Health Informatics New Zealand (HiNZ) Conference. (pp. 50). Retrieved from http://www.hinz.org.nz/
Chuah, Q., Chin, P., Hamilton, N., Gardiner, S., Strother, M., Dalton, S., Metcalf, S., & Doogue, M. (2017). Using electronic prescribing data to direct antimicrobial stewardship. Proceedings of the Health Informatics New Zealand (HiNZ) Conference. (pp. 107). Retrieved from http://www.hinz.org.nz/
McNeill, R., & Doogue, M. (2017). Pitfalls with medication safety data. Proceedings of the Health Informatics New Zealand (HiNZ) Conference. (pp. 72). Retrieved from http://www.hinz.org.nz/
Doogue, M., McNeill, R., Pugh, S., Sylevych, V., Wilkinson, J., & Young, M. (2017). Making adverse drug reactions visible. Proceedings of the Health Informatics New Zealand (HiNZ) Conference. (pp. 61). Retrieved from http://www.hinz.org.nz/
Kennedy, M. A., Maggo, S. D. S., Foulds, J., Luty, S., Chua, E. W., Cree, S., Ton, K., Liau, Y., Miller, A. L., Chin, P., … Doogue, M. (2017). DNA banking and genetic analysis of adverse drug reactions in the New Zealand healthcare setting. Proceedings of the American Society of Human Genetics (ASHG) Annual Meeting. 2123. Retrieved from http://www.ashg.org/2017meeting/
Leggett, C., Anderson, J., Couper, J., Doogue, M., Giles, L., & Pena, A. S. (2017). Metformin levels and adherence in children and adolescents with Type 1 diabetes enrolled in a 12 month randomised controlled trial. Hormone Research in Paediatrics, 88(Suppl. 1), (pp. 610-611). doi: 10.1159/000481424
Doogue, M., McGowan, A., Barclay, M., & Jardine, D. (2017). Multimorbidity, guidelines and polypharmacy. Clinical Therapeutics, 39(8, Suppl.), (pp. e17-e18). doi: 10.1016/j.clinthera.2017.05.055
Doogue, M., Crawford, A., Miller, H., Drennan, P., Chuah, Q., Strowther, M., & Chin, P. (2017). Evidenced based drug-drug interaction alerts in an E-prescribing system. Clinical Therapeutics, 39(8, Suppl.), (pp. e18). doi: 10.1016/j.clinthera.2017.05.058
Conference Contribution - Verbal presentation and other Conference outputs
Chin, P. K. L., Chuah, Q., & Doogue, M. P. (2017, September). Vignettes from electronic prescribing data. Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists New Zealand Section (ASCEPT-NZ) Annual Scientific Meeting, Queenstown, New Zealand.
Hamilton, N., Doogue, M., & Chuah-Richards, Q. (2017, September). Assessing documentation of "sulfur" adverse drug reactions in an electronic prescribing system. Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists New Zealand Section (ASCEPT-NZ) Annual Scientific Meeting, Queenstown, New Zealand.
McNeill, R., Chin, P., Coberger, E., & Doogue, M. (2017, September). Evaluation of patient information leaflets as a medication counselling tool. Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists New Zealand Section (ASCEPT-NZ) Annual Scientific Meeting, Queenstown, New Zealand.
2016
Journal - Research Article
Chin, P. K. L., & Doogue, M. P. (2016). Long-term prescribing of new oral anticoagulants. Australian Prescriber, 39(6), 200-204. doi: 10.18773/austprescr.2016.068
Khong, J. J., Burdon, K. P., Lu, Y., Laurie, K., Leonardos, L., Baird, P. N., … Doogue, M., … Craig, J. E. (2016). Pooled genome wide association detects association upstream of FCRL3 with Graves' disease. BMC Genomics, 17(1), 939. doi: 10.1186/s12864-016-3276-z
Lewis, B. C., Nair, P. C., Heran, S. S., Somogyi, A. A., Bowden, J. J., Doogue, M. P., & Miners, J. O. (2016). Warfarin resistance associated with genetic polymorphism of VKORC1: Linking clinical response to molecular mechamism using computational modeling. Pharmacogenetics & Genomics, 26(1), 44-50. doi: 10.1097/FPC.0000000000000184
Sanderson, C., Quinn, S. J., Agar, M., Chye, R., Clark, K., Doogue, M., … Currow, D. C. (2016). Pharmacovigilance in hospice/palliative care: Net effect of pregabalin for neuropathic pain. BMJ Supportive & Palliative Care, 6(3), 323-330. doi: 10.1136/bmjspcare-2014-000825
Journal - Research Other
Watts, G. J., Clark, K., Agar, M., Davidson, P. M., McDonald, C., Lam, L. T., … Doogue, M., … on behalf of the Australian national Palliative Care Clinical Studies Collaborative (PaCCSC). (2016). Study protocol: A phase III randomised, double-blind, parallel arm, stratified, block randomised, placebo-controlled trial investigating the clinical effect and cost-effectiveness of sertraline for the palliative relief of breathlessness in people with chronic breathlessness. BMJ Open, 6(11), e013177. doi: 10.1136/bmjopen-2016-013177
Conference Contribution - Published proceedings: Abstract
Coberger, E., Doogue, M., Ambrose, C., & Morahan, M.-C. (2016). Patient information leaflets: The digital transformation to MyMedicines. Proceedings of the Health Informatics New Zealand (HiNZ) Conference. (pp. 65). Retrieved from http://www.hinz.org.nz/
Doogue, M., Chin, P., Strother, M., Dean, K., Lodge, C., & Hamilton, N. (2016). Evidence based clinical decision support for e-prescribing and administration to reduce alert fatigue. Proceedings of the Health Informatics New Zealand (HiNZ) Conference. (pp. 70-71). Retrieved from http://www.hinz.org.nz/
Chuah, Q., Doogue, M., Strother, M., & Watson, A. (2016). Data extraction from an electronic prescribing and administration system. Proceedings of the Health Informatics New Zealand (HiNZ) Conference. (pp. 64). Retrieved from http://www.hinz.org.nz/
Chuah, Q., Chin, P. K. L., Vella-Brincat, J., Strother, R. M., Lodge, C., Dean, K., & Doogue, M. P. (2016). Drug-drug interaction and brand-prescribing alerts in an electronic prescribing and administration (ePA) system. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists and the Molecular Pharmacology of G Protein-Coupled Receptors (ASCEPT-MPGPCR) Joint Scientific Meeting. 536. Retrieved from http://www.asceptasm.com/
Hamilton, N., Barclay, M. L., & Doogue, M. P. (2016). Diagnosing and recording adverse drug reactions in general medical patients, a cross-sectional study. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists and the Molecular Pharmacology of G Protein-Coupled Receptors (ASCEPT-MPGPCR) Joint Scientific Meeting. 419. Retrieved from http://www.asceptasm.com/
Doogue, M. P. (2016). ePrescribing: The devil is in the detail. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists and the Molecular Pharmacology of G Protein-Coupled Receptors (ASCEPT-MPGPCR) Joint Scientific Meeting. 404. Retrieved from http://www.asceptasm.com/
Martin, J., Hilmer, S., Doogue, M., Soon, J., & Brett, J. (2016). High risk, poor evidence, often futile: Using EVOLVE to rank pharmacological treatments. Proceedings of the National Medicines Symposium. 370, (pp. 158). Retrieved from http://www.nps.org.au/about-us/what-we-do/campaigns-events/national-medicines-symposium
Wright, D. F. B., Doogue, M. P., Barclay, M. L., Chapman, P. T., Cross, N. B., Irvine, J. H., & Stamp, L. K. (2016). Predicting oxypurinol exposure in patients receiving intermittent haemodialysis. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Annual Scientific Meeting. (pp. 48). Retrieved from http://www.queenstownresearchweek.org/index.php/ascept-nz/
Hamilton, N., Barclay, M. L., & Doogue, M. P. (2016). Diagnosing and recording adverse drug reactions in general medical patients: A cross-sectional study. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Annual Scientific Meeting. (pp. 30). Retrieved from http://www.queenstownresearchweek.org/index.php/ascept-nz/
Chuah, Q., Vella-Brincat, J., Chin, P., Barclay, M., & Doogue, M. (2016). Use of clinical decision support in ePrescribing to facilitate generic prescribing. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Annual Scientific Meeting. (pp. 20). Retrieved from http://www.queenstownresearchweek.org/index.php/ascept-nz/
Wareing, T. R., Chin, P., Strother, R. M., Vella Brincat, J., Chuah, Q., & Doogue, M. P. (2016). Adverse drug reactions in an electronic prescribing and administration system. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Annual Scientific Meeting. (pp. 20). Retrieved from http://www.queenstownresearchweek.org/index.php/ascept-nz/
Drennan, P., Chin, P., Strother, M., Lodge, C., Dean, K., & Doogue, M. P. (2016). Drug-drug interaction alerts in an electronic prescribing system. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Annual Scientific Meeting. (pp. 16). Retrieved from http://www.queenstownresearchweek.org/index.php/ascept-nz/
Doogue, M. P., Chin, P., Strother, R. M., Lodge, C., Dean, K., & Hamilton, N. (2016). Clinical decision support in an electronic prescribing and administration system. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) Annual Scientific Meeting. (pp. 14). Retrieved from http://www.queenstownresearchweek.org/index.php/ascept-nz/
2015
Journal - Research Article
Chinnaratha, M. A., Chaudhary, S., Doogue, M., McCormick, R. J., Woodman, R. J., & Wigg, A. J. (2015). Prevalence of hepatic osteodystrophy and vitamin D deficiency in cirrhosis. Internal Medicine Journal, 45(12), 1230-1235. doi: 10.1111/imj.12866
Roberts, G. W., Quinn, S. J., Valentine, N., Alhawassi, T., O'Dea, H., Stranks, S. N., … Doogue, M. P. (2015). Relative hyperglycemia, a marker of critical illness: Introducing the Stress Hyperglycemia Ratio. Journal of Clinical Endocrinology & Metabolism, 100(12), 4490-4497. doi: 10.1210/jc.2015-2660
Dobinson, H. C., Anderson, T. P., Chambers, S. T., Doogue, M. P., Seaward, L., & Werno, A. M. (2015). Antimicrobial treatment options for granulomatous mastitis caused by Corynebacterium species. Journal of Clinical Microbiology, 53(9), 2895-2899. doi: 10.1128/jcm.00760-15
Sanderson, C., Quinn, S. J., Agar, M., Chye, R., Clark, K., Doogue, M., … Currow, D. C. (2015). Pharmacovigilance in hospice/palliative care: Net effect of gabapentin for neuropathic pain. BMJ Supportive & Palliative Care, 5, 273-280. doi: 10.1136/bmjspcare-2014-000699
Journal - Research Other
Clark, K., Quinn, S. J., Doogue, M., Sanderson, C., Lovell, M., & Currow, D. C. (2015). Routine prescribing of gabapentin or pregabalin in supportive and palliative care: What are the comparative performances of the medications in a palliative care population? Supportive Care in Cancer, 23(9), 2517-2520. doi: 10.1007/s00520-015-2837-z
Conference Contribution - Published proceedings: Abstract
Polasek, T. M., Thynne, T. R., & Doogue, M. P. (2015). Metformin in pregnant women with type 2 diabetes mellitus: Update on safety and efficacy. Proceedings of the Australasian Pharmaceutical Science Association and the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (APSA-ASCEPT) Joint Scientific Meeting: Drugs to Medicines: Up Close and Personal. 530. Retrieved from http://www.asceptasm.com/
McGowan, A., Jardine, D. L., Barclay, M. L., & Doogue, M. P. (2015). Complex patients, polypharmacy and guidelines. Proceedings of the Australasian Pharmaceutical Science Association and the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (APSA-ASCEPT) Joint Scientific Meeting: Drugs to Medicines: Up Close and Personal. 525. Retrieved from http://www.asceptasm.com/
Borrie, T. L., Young, M. L., Vella-Brincat, J. W. A., Doogue, M. P., & Pickering, J. W. (2015). Medication errors in patients undergoing elective surgery. Proceedings of the Australasian Pharmaceutical Science Association and the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (APSA-ASCEPT) Joint Scientific Meeting: Drugs to Medicines: Up Close and Personal. 511. Retrieved from http://www.asceptasm.com/
Doogue, M. P. (2015). The mis-diagnosis of adverse drug reactions. Proceedings of the Australasian Pharmaceutical Science Association and the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (APSA-ASCEPT) Joint Scientific Meeting: Drugs to Medicines: Up Close and Personal. 306. Retrieved from http://www.asceptasm.com/
Buffery, P. J., Metcalf, S., & Doogue, M. P. (2015). Cerebrospinal fluid pharmacokinetics of tobramycin following intraventricular administration. Proceedings of the Australasian Pharmaceutical Science Association and the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (APSA-ASCEPT) Joint Scientific Meeting: Drugs to Medicines: Up Close and Personal. 235. Retrieved from http://www.asceptasm.com/
Drennan, P., Chin, P., Strother, M., Lodge, C., Dean, K., & Doogue, M. (2015). Drug-drug interaction alerts in an electronic prescribing system. Proceedings of the Australasian Pharmaceutical Science Association and the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (APSA-ASCEPT) Joint Scientific Meeting: Drugs to Medicines: Up Close and Personal. 164. Retrieved from http://www.asceptasm.com/
Smith, M. M., Vella-Brincat, J., Robertshawe, B., & Doogue, M. P. (2015). The incidence of hospitalisation due to medicine induced rhabdomyolysis. Proceedings of the New Zealand Hospital Pharmacists' Association (NZHPA) Annual Conference. (pp. 93). Retrieved from http://www.nzhpa.org.nz/conferences--meetings.aspx
Allison, J., Vella-Brincat, J., & Doogue, M. P. (2015). Laxative co-prescribing with opioids on discharge from Christchurch hospitals. Proceedings of the New Zealand Hospital Pharmacists' Association (NZHPA) Annual Conference. (pp. 82). Retrieved from http://www.nzhpa.org.nz/conferences--meetings.aspx
Conference Contribution - Poster Presentation (not in published proceedings)
Vella-Brincat, J., Strother, M., McKean, A., & Doogue, M. P. (2015, September). Drug utilisation analysis from MedChart™ data. Poster session presented at the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists New Zealand Section (ASCEPT-NZ) Annual Scientific Meeting, Queenstown, New Zealand.
Conference Contribution - Verbal presentation and other Conference outputs
Maggo, S. D. S., Foulds, J., Luty, S. E., Miller, A. L., Kennedy, H., Doogue, M., & Kennedy, M. A. (2015, September). Understanding adverse drug reactions using genome sequencing (UDRUGS): Recent cases on SSRIs and SNRIs. Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists New Zealand Section (ASCEPT-NZ) Annual Scientific Meeting, Queenstown, New Zealand.
Doogue, M. P., Rowett, D., Devilee, L., To, T., & Currow, D. (2015, September). RAPID pharmacovigilance in palliative care. Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists New Zealand Section (ASCEPT-NZ) Annual Scientific Meeting, Queenstown, New Zealand.
2014
Journal - Research Article
Radhakutty, A., Shen, J., Hooper, A. J., Miller, S. A., Burnett, J. R., Mah, P. M., … Doogue, M. P. (2014). Quantification and genotyping of lipoprotein lipase in patients with diabetic lipaemia. Diabetic Medicine, 31(12), 1702-1707. doi: 10.1111/dme.12565
Snyder, B. D., Rowland, A., Polasek, T. M., Miners, J. O., & Doogue, M. P. (2014). Evaluation of felodipine as a potential perpetrator of pharmacokinetic drug-drug interactions. European Journal of Clinical Pharmacology, 70(9), 1115-1122. doi: 10.1007/s00228-014-1716-8
Chin, P. K. L., Wright, D. F. B., Patterson, D. M., Doogue, M. P., & Begg, E. J. (2014). A proposal for dose-adjustment of dabigatran etexilate in atrial fibrillation guided by thrombin time. British Journal of Clinical Pharmacology, 78(3), 599-609. doi: 10.1111/bcp.12364
Journal - Research Other
Upton, T. J., Hunt, P. J., & Doogue, M. P. (2014). Hyponatraemic seizure following arginine vasopressin for von Willebrand disease: Pernicious, predictable and preventable. Internal Medicine Journal, 44(5), 521-522. doi: 10.1111/imj.12404
Doogue, M. P. (2014). A safe and effective drug? New Zealand Medical Journal, 127(1404). Retrieved from http://www.nzma.org.nz/journal
Chin, P. K. L., Wright, D. F. B., Doogue, M. P., & Begg, E. J. (2014). Learning more from the dabigatran concentrations in RE-LY. JACC, 63(24), 2746-2747. doi: 10.1016/j.jacc.2013.11.069
Conference Contribution - Published proceedings: Abstract
Vella-Brincat, J., Kortegast, A., & Doogue, M. (2014). Oxycodone and other analgesics prescribing on discharge from Christchurch Hospital. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) and the Molecular Pharmacology of G Protein-Coupled Receptors (MPGPCR) Joint Scientific Meeting. (pp. 46). Retrieved from http://www.asceptasm.com/
Polasek, T. M., Snyder, B. D., Rowland, A., Miners, J. O., & Doogue, M. P. (2014). In vivo evaluation of felodipine as an inhibitor of cytochrome P450 enzymes and P-glycoprotein. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) and the Molecular Pharmacology of G Protein-Coupled Receptors (MPGPCR) Joint Scientific Meeting. (pp. 44). Retrieved from http://www.asceptasm.com/
Conference Contribution - Verbal presentation and other Conference outputs
Doogue, M. (2014, November). Liver transplant donor and recipient CYP3A5 and ABCB1 genetics and tacrolimus pharmacokinetics. Verbal presentation at the 10th Annual Carney Pharmacogenomics Symposium, Christchurch, New Zealand.
Doogue, M. (2014, August). Adverse drug reaction, failures in diagnosis. Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists New Zealand Section (ASCEPT-NZ) Annual Scientific Meeting, Queenstown, New Zealand.
2013
Journal - Research Article
Kennedy, N. A., Asser, T. L., Mountifield, R. E., Doogue, M. P., Andrews, J. M., & Bampton, P. A. (2013). Thiopurine metabolite measurement leads to changes in management of inflammatory bowel disease. Internal Medicine Journal, 43(3), 278-286. doi: 10.1111/j.1445-5994.2012.02936.x
To, T. H. M., Agar, M., Shelby-James, T., Abernethy, A. P., Doogue, M., Rowett, D., … Currow, D. C. (2013). Off-label prescribing in palliative care: A cross-sectional national survey of palliative medicine doctors. Palliative Medicine, 27(4), 320-328. doi: 10.1177/0269216312464263
Burt, M. G., Mangelsdorf, B. L., Rogers, A., Ho, J. T., Lewis, J. G., Inder, W. J., & Doogue, M. P. (2013). Free and total plasma cortisol measured by immunoassay and mass spectrometry following ACTH1-24 stimulation in the assessment of pituitary patients. Journal of Clinical Endocrinology & Metabolism, 98(5), 1883-1890. doi: 10.1210/jc.2012-3576
Crawford, G. B., Agar, M., Quinn, S. J., Phillips, J., Lister, C., Michael, N., Doogue, M., … Currow, D. C. (2013). Pharmacovigilance in hospice/palliative care: Net effect of haloperidol for delirium. Journal of Palliative Medicine, 16(11), 1335-1341. doi: 10.1089/jpm.2013.0230
Polasek, T. M., Patel, F., Jensen, B. P., Sorich, M. J., Wiese, M. D., & Doogue, M. P. (2013). Predicted metabolic drug clearance with increasing adult age. British Journal of Clinical Pharmacology, 75(4), 1019-1028. doi: 10.1111/j.1365-2125.2012.04446.x
Journal - Research Other
Phillips, C. J., Doan, H., Kirkpatrick, C. M. J., Gordon, D. L., & Doogue, M. P. (2013). An educational intervention to improve vancomycin prescribing and monitoring. International Journal of Antimicrobial Agents, 41(4), 393-394. doi: 10.1016/j.ijantimicag.2012.11.010
Doogue, M. P., & Polasek, T. M. (2013). The ABCD of clinical pharmacokinetics. Therapeutic Advances in Drug Safety, 4(1), 5-7. doi: 10.1177/ 2042098612469335
Thynne, T. R. J., & Doogue, M. P. (2013). A dose of paracetamol for the levothyroxine absorption test. Clinical Endocrinology, 78(6), 968-969. doi: 10.1111/cen.12211
Jones, G. R. D., Bryant, S., Fullinfaw, R., Ilett, K., Miners, J. O., Morris, R. G., & Doogue, M. P. (2013). Mass or molar? Recommendations for reporting concentrations of therapeutic drugs. Medical Journal of Australia, 198, 368-369. doi: 10.5694/mja12.10366
Fazal, M. W., Doogue, M. P., Leong, R. W., Bampton, P. A., & Andrews, J. M. (2013). Allopurinol use in pregnancy in three women with inflammatory bowel disease: Safety and outcomes: A case series. BMC Gastroenterology, 13, 172. doi: 10.1186/1471-230X-13-172
Doogue, M. P., & Thynne, T. R. J. (2013). Product information for generic drugs: Old, unloved and sometimes unsafe. Internal Medicine Journal, 43(12), 1346-1348. doi: 10.1111/imj.12295
Doogue, M. P., & Thynne, T. R. J. (2013). What is quality of medicines? Internal Medicine Journal of Thailand, 43(10), 1057-1058. doi: 10.1111/imj.12263
Conference Contribution - Verbal presentation and other Conference outputs
Buffery, P. J., Barclay, M. L., Doogue, M. P., Moore, G. A., & Kennedy, M. A. (2013, August). Codeine, breastfeeding and infant narcosis: A cautionary case. Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists New Zealand Section (ASCEPT-NZ) Annual Scientific Meeting, Queenstown, New Zealand.
2012
Journal - Research Article
Joseph, S. P., Ho, J. T., Doogue, M. P., & Burt, M. G. (2012). Perioperative management of the hypothalamic-pituitary-adrenal axis in patients with pituitary adenomas: An Australasian survey. Internal Medicine Journal, 42(10), 1120-1124. doi: 10.1111/j.1445-5994.2011.02582.x
Currow, D. C., Vella-Brincat, J., Fazekas, B., Clark, K., Doogue, M., & Rowett, D. (2012). Pharmacovigilance in hospice/palliative care: Rapid report of net clinical effect of metoclopramide. Journal of Palliative Medicine, 15(10), 1071-1075. doi: 10.1089/jpm.2012.0111
Journal - Research Other
Snyder, B., Polasek, T. M., & Doogue, M. P. (2012). Reply to: Graefe-Mody U, Friderich C, Port A et al. Effect of renal impairment on the pharmacokinetics of the dipeptidyl peptidase-4 inhibitor linagliptin. Diabetes Obes Metab 2011; 13: 939-946. Diabetes, Obesity & Metabolism, 14(7), 670. doi: 10.1111/j.1463-1326.2012.01588.x
Campbell, K. A., Joseph, S. P., Whiting, M. J., & Doogue, M. P. (2012). The half-lives of plasma free metanephrines. Clinical Endocrinology, 76, 764-766. doi: 10.1111/j.1365-2265.2011.04273.x
Currow, D. C., Rowett, D., Doogue, M., To, T. H. M., & Abernethy, A. P. (2012). An international initiative to create a collaborative for pharmacovigilance in hospice and palliative care clinical practice. Journal of Palliative Medicine, 15(3), 282-286. doi: 10.1089/jpm.2012.9605
Campbell, K., & Doogue, M. (2012). Evaluating and managing patients with thyrotoxicosis. Australian Family Physician, 41(8), 564-572. [Case Study].
Journal - Professional & Other Non-Research Articles
Johnson, D. W., Jones, G. R. D., Mathew, T. H., Ludlow, M. J., Doogue, M. P., Jose, M. D., … Australasian Creatinine Consensus Working Group. (2012). Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: New developments and revised recommendations [Position statement]. Medical Journal of Australia, 197(4), 222-223. doi: 10.5694/mja11.11329
2011
Conference Contribution - Published proceedings: Abstract
Patel, F., Jensen, B. P., Doogue, M. P., & Polasek, T. M. (2011). Effects of adult age on predicted total drug clearance. Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) - Australian Physiological Society (AuPS) - High Blood Pressure Research Council of Australia (HBPRCA) Joint Meeting. Retrieved from http://ascept2011.eproceedings.com.au/papers/p5.pdf
2009
Journal - Research Article
Schouten, B. J., Doogue, M. P., Soule, S. G., & Hunt, P. J. (2009). Iron polymaltose-induced FGF23 elevation complicated by hypophosphataemic osteomalacia. Annals of Clinical Biochemistry, 46(2), 167-169. doi: 10.1258/acb.2008.008151
Doogue, M. P., Begg, E. J., Moore, M. P., Lunt, H., Pemberton, C. J., & Zhang, M. (2009). Metformin increases plasma ghrelin in Type 2 diabetes. British Journal of Clinical Pharmacology, 68(6), 875-882. doi: 10.1111/j.1365-2125.2009.03372.x
2008
Journal - Research Other
Sung, E. Y. Y., Moore, M. P., Lunt, H., Doogue, M., Zhang, M., & Begg, E. J. (2008). Do thiazide diuretics alter the pharmacokinetics of metformin in patients with type 2 diabetes already established on metformin? [Letter to the editor]. British Journal of Clinical Pharmacology, 67(1), 130-131. doi: 10.1111/j.1365-2125.2008.03302.x
2007
Journal - Research Other
Doogue, M., Soule, S., & Hunt, P. (2007). Another cause of 'pseudophaeochromocytoma': Quetiapine associated with a false positive normetanephrine result. Clinical Endocrinology, 67, 472-476.
2006
Journal - Research Article
Lewis, J. G., möpert, B., Shand, B. I., Doogue, M. P., Soule, S. G., Frampton, C. M., & Elder, P. A. (2006). Plasma variation of corticosteroid-binding globulin and sex hormone-binding globulin. Hormone & Metabolic Research, 38, 241-245.
Gardiner, S. J., Doogue, M. P., Zhang, M., & Begg, E. J. (2006). Quantification of infant exposure to celecoxib through breast milk. British Journal of Clinical Pharmacology, 61(1), 101-104. doi: 10.1111/j.1365-2125.2005.02520.x
2005
Authored Book - Other
Beard, M. E. J., Thwaites, J. H., Chambers, S. T., Colls, B. M., Doogue, M., Jeffery, M., … Pithie, A., … Sainsbury, R. (2005). Management guidelines for common medical conditions (11th ed.). Christchurch, NZ: Canterbury District Health Board, 271p.
Journal - Research Other
Doogue, M. P., Begg, E. J., & Bridgman, P. (2005). Clopidogrel hypersensitivity syndrome with rash, fever, and neutropenia. Mayo Clinic Proceedings, 80(10), 1368-1370.
Conference Contribution - Published proceedings: Abstract
Doogue, M. P., Begg, E. J., Moore, M. P., Lunt, H., Zhang, M., & Pemberton, C. (2005). Metformin pharmacokinetics and the effect on hormones involved in appetite regulation. Proceedings of the Joint Meeting of ASCEPT and APSA. ASCEPT: Melbourne, Australia. [Abstract]
Conference Contribution - Poster Presentation (not in published proceedings)
Barclay, M. L., Begg, E. J., Gefken, T., & Doogue, M. P. (2005, December). Interactive computer graphics for enhancing learning of clinical pharmacology. Poster session presented at the Joint Meeting of ASCEPT and APSA, Melbourne, Australia.
Conference Contribution - Verbal presentation and other Conference outputs
Cromie, A. J., Doogue, M. P., Vella-Brincat, J., & Barclay, M. L. (2005, August). Therapeutic drug monitoring of tricyclic antidepressants: What is happening in Christchurch? Verbal presentation at the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists New Zealand Scientific Meeting, Wellington, New Zealand.
Doogue, M. P., Begg, E. J., Moore, M. P., Lunt, H., & Zhang, M. (2005, December). Metformin pharmacokinetics and the effect on hormones involved in appetite regulation. Verbal presentation at the Joint Meeting of ASCEPT and APSA, Melbourne, Australia.
Dalrymple, J., Begg, E., Doogue, M., Wright, D., Carroll, G., & Grant, K. (2005, August). Medicines information leaflets for patients in New Zealand. Verbal presentation at the Ascept New Zealand Scientific Meeting, Wellington, New Zealand.
Software
Barclay, M., Begg, E., Doogue, M., & Gefken, T. (2005). Interactive Clinical Pharmacology (Version http://www.icp.org.nz/about.htm) [Computer Software]. Dunedin, New Zealand: Department of Clinical Pharmacology, University of Otago. Retrieved from http://www.icp.org.nz/about.htm
2004
Edited Book - Other
Begg, E., Barclay, M., Vella-Brincat, J., Gardiner, S. J., Doogue, M., McDermott, L., … Chambers, S., & Murdoch, D. (Eds.). (2004). Preferred Medicines List (8th ed.). Christchurch: The Caxton Press, 172p.
Journal - Research Other
Doogue, M. P., Gardiner, S. J., & Begg, E. J. (2004). Comment: Prediction of milk/plasma concentration ratio of drugs. Annals of Pharmacotherapy, 38(1), 174-175.
Doogue, M. P., Gardiner, S. J., & Begg, E. J. (2004). Comment: Prediction of milk/plasma concentration ratio of drugs [Letter]. Annals of Pharmacotherapy, 38, 174-175.
Conference Contribution - Published proceedings: Abstract
Barclay, M. L., Patton, N., Kirkpatrick, C. M. J., Moore, G. A., & Doogue, M. P. (2004). Population pharmacokinetic analysis of high-dose oral busulphan for bone marrow transplantation in adults and children. Clinical & Experimental Pharmacology & Physiology, 31(Suppl. 1), (pp. A174). doi: 10.1111/j.1440-1681.2004.cep_4027.pdf.x
1999
Journal - Research Article
Jackson, N. W., Doogue, M. P., & Elliott, J. M. (1999). Priority points and cardiac events while waiting for coronary bypass surgery. Heart, 81(4), 367-373. doi: 10.1136/hrt.81.4.367
1998
Journal - Research Article
Doogue, M. P., Choong, C. K., & Frizelle, F. A. (1998). Recurrent gallstone ileus. Australian & New Zealand Journal of Surgery, 68, 755-757.
Conference Contribution - Published proceedings: Abstract
Elliott, J. M., Jackson, N. W., Doogue, M. P., & Smyth, D. W. (1998). Has the prognosis for left main (LM) and left main equivalent (LMEQ) coronary disease changed: analysis of a long waiting list. Proceedings of the 47th Annual Scientific Session of the American College. 31(2), (pp. 214A). Journal of the American College of Cardiology. [Abstract]
Jackson, N. W., Doogue, M. P., Crozier, I. G., Ikram, H., Richards, A. M., Smyth, D. W., & Elliott, J. M. (1998). Waiting for coronary artery bypass surgery (CABG) in Christchurch. Proceedings of the New Zealand Regional Meeting of the Cardiac Society of Australia and New Zealand. 111(1067 (sup)), (pp. 41). New Zealand Medical Journal. [Abstract]
Doogue, M. P., Brett, C. N. H., Brouard, P. D., Crozier, I. G., Hull, F. T. L., Ikram, H., Richards, A. M., Smyth, D. W., & Elliott, J. M. (1998). Waiting times for coronary artery bypass surgery (CABG) in New Zealand: comparisons with Canada. Proceedings of New Zealand Regional Scientific Meeting of the Cardiac Society of Australia and New Zealand. 111(1067), (pp. 30). Auckland: New Zealand Medical Journal. [Abstract]
Elliott, J. M., Doogue, M. P., Brett, C. N. H., & Ormiston, J. O. (1998). Coronary angiography, angioplasty (PTCA) and bypass surgery (CABG) in New Zealand (NZ): a survey of waiting times. Proceedings of New Zealand Regional Scientific Meeting of the Cardiac Society of Australia and New Zealand. 111(1067 (Sup)), (pp. 28). Auckland: New Zealand Medical Journal. [Abstract]
Elliott, J. M., Jackson, N. W., Doogue, M. P., & Smyth, D. W. (1998). Has the prognosis for left main (LM) coronary artery disease changed: observations from a long waiting list. Proceedings of the New Zealand Regional Meeting of Cardiac Society of Australia and New Zealand. 111(1067 (sup)), (pp. 37). Rotorua: New Zealand Medical Journal. [Abstract]
1997
Journal - Research Article
Doogue, M. P., Brett, C. N. H., & Elliott, J. M. (1997). Life and death on the waiting list for coronary bypass surgery. New Zealand Medical Journal, 110(1037).